Amphastar Boosted By Baqsimi And Shortages
The Recently Acquired Asset Drove Company Revenue Growth In Q1
The American pharma reported first quarter results that highlighted the ongoing impact of shortages affecting Amphastar’s competitors, alongside the first sales of Baqsimi.
